BRK targets Dok1 for ubiquitin-mediated proteasomal degradation to promote cell proliferation and migration.
Breast tumor kinase (BRK), also known as protein tyrosine kinase 6 (PTK6), is a non-receptor tyrosine kinase overexpressed in more that 60% of human breast carcinomas. The overexpression of BRK has been shown to sensitize mammary epithelial cells to mitogenic signaling and to promote cell proliferat...
Guardado en:
Autores principales: | Sayem Miah, Raghuveera Kumar Goel, Chenlu Dai, Natasha Kalra, Erika Beaton-Brown, Edward T Bagu, Keith Bonham, Kiven E Lukong |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0eb0e42ee72c498a98472e66fd3b4c9a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Open-gate mutants of the mammalian proteasome show enhanced ubiquitin-conjugate degradation
por: Won Hoon Choi, et al.
Publicado: (2016) -
Pharmacological Modulation of Ubiquitin-Proteasome Pathways in Oncogenic Signaling
por: Anmol Sharma, et al.
Publicado: (2021) -
Tripartite degrons confer diversity and specificity on regulated protein degradation in the ubiquitin-proteasome system
por: Mainak Guharoy, et al.
Publicado: (2016) -
Regulation of energy homeostasis by the ubiquitin-independent REGγ proteasome
por: Lianhui Sun, et al.
Publicado: (2016) -
The structure of the ubiquitin-like modifier FAT10 reveals an alternative targeting mechanism for proteasomal degradation
por: Annette Aichem, et al.
Publicado: (2018)